Synthesize Bio logo

Synthesize Bio

synthesize.bio

Synthesize Bio develops generative genomics models that predict how human tissues and cells respond to drugs, diseases, and experimental interventions. Its platform enables drug development teams, clinical development teams, and biopharma partners to simulate clinical trial outcomes, optimize trial design, identify biomarkers, and augment limited datasets with virtual human cohorts. The organization aims to accelerate and de-risk clinical development by providing actionable predictions and insights grounded in large-scale RNA-seq data.

Facts

HQ
Seattle, WA, US
Sectors
Biotechnology Research
Founded
2023
Type
Corporation Seattle business license
Employees
21
Registered name
Synthesize Bio Seattle business license
Stage
Seed
Founders
Robert Bradley, PhD, Jeff Leek, PhD

Is this your organization? Claim it

The Future of Biology Is Generative: Inside Synthesize Bio's RNA AI Model

In this episode of Founded & Funded, Madrona Investor Joe Horsman sits down with Jeff Leek and Rob Bradley, co-founders of Synthesize Bio, a foundation model company for biology that's unlocking experiments researchers could never run in the lab. Jeff, chief data officer at the Fred Hutch Cancer Center, and Rob, the McIlwain Family endowed chair in data science, share: •Why a startup the right fit for generative genomics •How generative genomics could reshape research, drug trials, and more •Why RNA is the right starting point for a generative AI model in biology •What this breakthrough means for the future…

Taxes: A Candid Conversation with Conservative Innovator Matt McIllwain

In this episode, host Leigh Morgan welcomes Matt McIlwain—managing director at Madrona Venture Group, respected civic leader in Seattle, and fellow board member at the Fred Hutch Cancer Center—for a thoughtful and deeply human conversation. Together, they explore questions at the intersection of tax policy, constructive dialogue, and the responsibilities we carry as citizens navigating a polarized time. While their views on policy may differ they both have a shared commitment to curiosity, listening, and mutual respect provided a model for how to talk through even the most emotive and controversial topics. One of those topics, tax policy, is often…

#64 Matt McIlwain – MD Madrona Venture Group on all Things Venture Capital

Nataraj interviewed veteran VC Matt McIlwain of Madrona Venture Group on Startup Project podcast. Matt shared his insights into the state of venture capital and the impacts of AI, drawn from his 20+ years of experience. Some key takeaways: 1. Venture is a "tale of two cities" now - later stage startups are struggling, earlier stage companies embracing AI are thriving 2. Seattle has unmatched talent but lacks local capital - still over-reliant on Silicon Valley VCs 3. Incumbents have the edge currently in leveraging AI due to data, customers, ability to integrate via APIs - but long term, AI-native…

See all 8 podcast episodes about Synthesize Bio.

People

  • Jeff Leek
    Jeff Leek Co-founder, Co-CEO
  • Alice M. Walsh Executive, COO

Online